Table 2.
Outcome | No studies | MUFA source | Relative risk | 95% CI | p-value | I 2 (%) a 95% CI |
---|---|---|---|---|---|---|
All-cause mortality | 17 | All MUFA combined | 0.89 | 0.83 to 0.96 | 0.001 | 64 |
42 to 78 | ||||||
5 | MUFA | 1.00 | 0.93 to 1.08 | 0.93 | 23 | |
10 | MUFA:SFA | 0.90 | 0.82 to 1.00 | 0.04 | 59 | |
5 | Olive oil | 0.77 | 0.71 to 0.84 | <0.00001 | 0 | |
Cardiovascular mortality | 14 | All MUFA combined | 0.88 | 0.80 to 0.96 | 0.004 | 50 |
15 to 71 | ||||||
8 | MUFA | 0.96 | 0.89 to 1.04 | 0.36 | 7 | |
4 | MUFA:SFA | 0.91 | 0.83 to 0.99 | 0.04 | 0 | |
5 | Olive oil | 0.70 | 0.48 to 1.03 | 0.07 | 71 | |
1 | Oleic acid | 0.81 | 0.66 to 0.99 | 0.04 | n.a. | |
Combined cardiovascular events | 30 | All MUFA combined | 0.91 | 0.86 to 0.96 | 0.001 | 58 |
38 to 71 | ||||||
20 | MUFA | 0.95 | 0.89 to 1.02 | 0.14 | 52 | |
6 | MUFA:SFA | 0.93 | 0.86 to 1.01 | 0.07 | 0 | |
7 | Olive oil | 0.72 | 0.57 to 0.91 | 0.007 | 75 | |
1 | Oleic acid | 0.87 | 0.76 to 1.00 | 0.04 | n.a. | |
Stroke | 11 | All MUFA combined | 0.83 | 0.71 to 0.97 | 0.02 | 70 |
46 to 84 | ||||||
9 | MUFA | 0.85 | 0.72 to 1.01 | 0.07 | 65 | |
1 | MUFA:SFA | 1.18 | 0.91 to 1.53 | 0.21 | n.a. | |
2 | Olive oil | 0.60 | 0.47 to 0.77 | <0.0001 | 0 | |
Coronary heart disease | 15 | All MUFA combined | 0.96 | 0.90 to 1.01 | 0.13 | 41 |
0 to 66 | ||||||
9 | MUFA | 0.99 | 0.93 to 1.06 | 0.76 | 29 | |
4 | MUFA:SFA | 0.94 | 0.86 to 1.02 | 0.14 | 0 | |
4 | Olive oil | 0.80 | 0.57 to 1.14 | 0.22 | 77 | |
1 | Oleic acid | 0.87 | 0.76 to 1.00 | 0.04 | n.a. |
a I 2 inconsistency, percentage of variation across studies due to heterogeneity.
MUFA monounsaturated fatty acids, n.a. not applicable, SFA saturated fatty acids.